… , Acinetobacter baumannii, Pseudomonas aeruginosa, and … baumannii infections, there is
mounting pressure to find new … While A.baumannii remains a major public health challenge …

… It is intrinsically resistant to many antimicrobial agents and additional acquired … to
ceftolozane-tazobactam has been identified in P. … aeruginosa, in challenging clinical situations …

… to not just search for new antimicrobial agents but to come up … resistant strains of Pseudomonas
aeruginosa infections is ever… coli and Acinetobacter baumannii. Podlesek and Bertok 53 …

… identification in less than 40% of patients with clinically diagnosed IVACs [12]. This has
traditionally made challenging … ; (b) to appropriately place novel antimicrobial agents in lack of …

… and irresponsible sale of antibiotic drugs, particularly in … typhimurium, and Pseudomonas
aeruginosa. Further progression into … Acinetobacter baumannii is one the most dangerous and …

… , Acinetobacter baumannii, Pseudomonas aeruginosa, and … baumannii, Pseudomonas
aeruginosa, and Enterobacter spp… nonsusceptible to selected antimicrobial agents. Vancomycin …

… preferred regimens have not been identified, we advocate for … CR Enterobacterales and
Pseudomonas aeruginosa do not … , treatment of CRAB infections remains a major challenge for …

… infections caused by multi-drug resistant bacteria in animal and human medicine have forced
us to find new antibacterial … ’ Pseudomonas aeruginosa, Acinetobacter baumannii, and …

… baumannii, with the objective of identifying the most … that effectively escape the effects
of antibacterial drugs [16]. … such as Pseudomonas aeruginosa, Acinetobacter baumannii, …

… launching of new antibacterial agents in the last few decades has decreased due to difficulties
in … to more rapidly identify new drugs and/or drug combinations applicable to these difficult …